159 related articles for article (PubMed ID: 23748484)
1. Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.
Pashos CL; Flowers CR; Kay NE; Weiss M; Lamanna N; Farber C; Lerner S; Sharman J; Grinblatt D; Flinn IW; Kozloff M; Swern AS; Street TK; Sullivan KA; Harding G; Khan ZM
Support Care Cancer; 2013 Oct; 21(10):2853-60. PubMed ID: 23748484
[TBL] [Abstract][Full Text] [Related]
2. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
Holtzer-Goor KM; Schaafsma MR; Joosten P; Posthuma EF; Wittebol S; Huijgens PC; Mattijssen EJ; Vreugdenhil G; Visser H; Peters WG; Erjavec Z; Wijermans PW; Daenen SM; van der Hem KG; van Oers MH; Uyl-de Groot CA
Qual Life Res; 2015 Dec; 24(12):2895-906. PubMed ID: 26205768
[TBL] [Abstract][Full Text] [Related]
3. Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.
Else M; Smith AG; Cocks K; Richards SM; Crofts S; Wade R; Catovsky D
Br J Haematol; 2008 Dec; 143(5):690-7. PubMed ID: 19016733
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect
Sharman JP; Cocks K; Nabhan C; Lamanna N; Kay NE; Grinblatt DL; Flowers CR; Davids MS; Kiselev P; Swern AS; Sullivan K; Gharibo MM; Flick ED; Trigg A; Mato A
EJHaem; 2020 Jul; 1(1):188-198. PubMed ID: 35847738
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents.
Waweru C; Kaur S; Sharma S; Mishra N
Curr Med Res Opin; 2020 Sep; 36(9):1481-1495. PubMed ID: 32634056
[TBL] [Abstract][Full Text] [Related]
6. Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study.
Cramer P; Fraser G; Santucci-Silva R; Grosicki S; Dilhuydy MS; Janssens A; Loscertales J; Rule S; Goy A; Traina S; Chan EKH; Diels J; Sengupta N; Mahler M; Salman M; Howes A; Chanan-Khan A
Leuk Lymphoma; 2018 Sep; 59(9):2075-2084. PubMed ID: 29295653
[TBL] [Abstract][Full Text] [Related]
7. Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia.
Robbertz AS; Weiss DM; Awan FT; Byrd JC; Rogers KA; Woyach JA
Support Care Cancer; 2020 Apr; 28(4):1799-1807. PubMed ID: 31332513
[TBL] [Abstract][Full Text] [Related]
8. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
Jain P; Keating M; Renner S; Cleeland C; Xuelin H; Gonzalez GN; Harris D; Li P; Liu Z; Veletic I; Rozovski U; Jain N; Thompson P; Bose P; DiNardo C; Ferrajoli A; O'Brien S; Burger J; Wierda W; Verstovsek S; Kantarjian H; Estrov Z
Lancet Haematol; 2017 Feb; 4(2):e67-e74. PubMed ID: 28089238
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia.
Goyal NG; Maddocks KJ; Johnson AJ; Byrd JC; Westbrook TD; Andersen BL
Ann Behav Med; 2018 Mar; 52(4):287-298. PubMed ID: 30084895
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Agarwal N; McQuarrie K; Bjartell A; Chowdhury S; Pereira de Santana Gomes AJ; Chung BH; Özgüroğlu M; Juárez Soto Á; Merseburger AS; Uemura H; Ye D; Given R; Cella D; Basch E; Miladinovic B; Dearden L; Deprince K; Naini V; Lopez-Gitlitz A; Chi KN;
Lancet Oncol; 2019 Nov; 20(11):1518-1530. PubMed ID: 31578173
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
Shanafelt TD; Bowen D; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Sloan JA; Call TG
Br J Haematol; 2007 Oct; 139(2):255-64. PubMed ID: 17897301
[TBL] [Abstract][Full Text] [Related]
14. Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial.
Montillo M; Illés Á; Robak T; Pristupa AS; Wach M; Egyed M; Delgado J; Jurczak W; Morschhauser F; Schuh A; Eradat H; Shreay S; Barrientos JC; Zelenetz AD
Health Qual Life Outcomes; 2019 Nov; 17(1):173. PubMed ID: 31729982
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Chinese EORTC chronic lymphocytic leukaemia module - application of classical test theory and item response theory.
Dong D; Jin J; Oerlemans S; Yu S; Yang S; Zhu J; Xu RH
Health Qual Life Outcomes; 2020 Apr; 18(1):96. PubMed ID: 32264961
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.
Holzner B; Kemmler G; Kopp M; Nguyen-Van-Tam D; Sperner-Unterweger B; Greil R
Eur J Haematol; 2004 Jun; 72(6):381-9. PubMed ID: 15128416
[TBL] [Abstract][Full Text] [Related]
17. Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.
Kantarjian HM; Mamolo CM; Gambacorti-Passerini C; Cortes JE; Brümmendorf TH; Su Y; Reisman AL; Shapiro M; Lipton JH
Cancer; 2018 Feb; 124(3):587-595. PubMed ID: 29072772
[TBL] [Abstract][Full Text] [Related]
18. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
Strickland G; Pauling J; Cavill C; McHugh N
Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
[TBL] [Abstract][Full Text] [Related]
19. The relation of illness perceptions to stress, depression, and fatigue in patients with chronic lymphocytic leukaemia.
Westbrook TD; Maddocks K; Andersen BL
Psychol Health; 2016 Jul; 31(7):891-902. PubMed ID: 26982998
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia: economic burden and quality of life: literature review.
Stephens JM; Gramegna P; Laskin B; Botteman MF; Pashos CL
Am J Ther; 2005; 12(5):460-6. PubMed ID: 16148431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
